Screener
Viridian Therapeutics, Inc. VRDN Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s total assets?
- Viridian Therapeutics, Inc. (VRDN) reported total assets of $1.1B in Q2 2026.
- How has Viridian Therapeutics, Inc.'s total assets changed year-over-year?
- Viridian Therapeutics, Inc.'s total assets increased by 88.4% year-over-year, from $582.32M to $1.1B.
- What is the long-term trend for Viridian Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s total assets has grown at a 46.9% compound annual growth rate (CAGR), from $131.26M to $899.42M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Viridian Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude